Brainstem and cervical spinal cord Fos immunoreactivity evoked by nerve growth factor injection into neck muscles in mice.
Although myofascial tenderness is thought to play a key role in the pathophysiology of tension-type headache, very few studies have addressed neck muscle nociception. The neuronal activation pattern following local nerve growth factor (NGF) administration into semispinal neck muscles in anaesthetized mice was investigated using Fos protein immunohistochemistry. In order to differentiate between the effects of NGF administration on c-fos expression and the effects of surgical preparation, needle insertion and intramuscular injection, the experiments were conducted in three groups. In the sham group (n=7) cannula needles were only inserted without any injection. In the saline (n=7) and NGF groups (n=7) 0.9% physiological saline solution or 0.8 microm NGF solution were injected in both muscles, respectively. In comparison with sham and saline conditions, NGF administration induced significantly stronger Fos immunoreactivity in the mesencephalic periaqueductal grey (PAG), the medullary lateral reticular nucleus (LRN), and superficial layers I and II of cervical spinal dorsal horns C1, C2 and C3. This activation pattern corresponds very well to central nervous system processing of deep noxious input. A knowledge of the central anatomical representation of neck muscle pain is an essential prerequisite for the investigation of neck muscle nociception in order to develop a future model of tension-type headache.
Panfil
C
C
Department of Neurosurgery, Experimental Neurosurgery Section, RWTH Aachen University, Aachen, Germany.
Makowska
A
A
Ellrich
J
J
D000818:Animals; D001933:Brain Stem / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D002574:Cervical Vertebrae / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009209:Myofascial Pain Syndromes / Q000276:immunology / Q000378:metabolism*; D009334:Neck Muscles / Q000187:drug effects* / Q000276:immunology; D020932:Nerve Growth Factor / Q000008:administration & dosage*; D016760:Proto-Oncogene Proteins c-fos / Q000276:immunology / Q000378:metabolism*; D013116:Spinal Cord / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D018781:Tension-Type Headache / Q000139:chemically induced / Q000276:immunology / Q000378:metabolism*; D014018:Tissue Distribution
D016760:Proto-Oncogene Proteins c-fos; D020932:Nerve Growth Factor